
Amwill Health Care (AMWILL) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2024Income Metrics
Revenue
81.6M
Gross Profit
58.1M
71.21%
Operating Income
18.9M
23.15%
Net Income
15.3M
18.78%
Balance Sheet Metrics
Total Assets
714.8M
Total Liabilities
22.6M
Shareholders Equity
692.2M
Debt to Equity
0.03
Cash Flow Metrics
Operating Cash Flow
-24.2M
Free Cash Flow
-52.7M
Revenue & Profitability Trend
Amwill Health Care Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 405.8M | 439.5M | 301.7M | 276.1M | 180.0M |
Cost of Goods Sold | 115.1M | 120.3M | 90.7M | 87.7M | 80.3M |
Gross Profit | 290.7M | 319.2M | 211.0M | 188.4M | 99.7M |
Gross Margin % | 71.6% | 72.6% | 69.9% | 68.2% | 55.4% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | - | 45.8M | 48.2M | 53.7M | 47.8M |
Other Operating Expenses | 102.2M | 96.7M | 43.4M | 28.5M | 23.4M |
Total Operating Expenses | 102.2M | 142.6M | 91.6M | 82.2M | 71.2M |
Operating Income | 112.0M | 164.3M | 41.5M | 38.3M | -10.3M |
Operating Margin % | 27.6% | 37.4% | 13.8% | 13.9% | -5.7% |
Non-Operating Items | |||||
Interest Income | - | 3.1M | 1.2M | 22.0K | 0 |
Interest Expense | - | - | - | - | - |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 119.0M | 167.6M | 41.7M | 33.3M | -10.3M |
Income Tax | 11.7M | 42.6M | 10.6M | 7.6M | -333.0K |
Effective Tax Rate % | 9.9% | 25.4% | 25.4% | 22.8% | 0.0% |
Net Income | 107.3M | 125.0M | 31.1M | 25.7M | -10.0M |
Net Margin % | 26.4% | 28.4% | 10.3% | 9.3% | -5.5% |
Key Metrics | |||||
EBITDA | 116.5M | 166.7M | 44.9M | 46.6M | -10.2M |
EPS (Basic) | - | ₹6.25 | ₹1.56 | ₹1.29 | ₹-0.50 |
EPS (Diluted) | - | ₹6.25 | ₹1.56 | ₹1.29 | ₹-0.50 |
Basic Shares Outstanding | - | 20003600 | 20003600 | 20003600 | 20003600 |
Diluted Shares Outstanding | - | 20003600 | 20003600 | 20003600 | 20003600 |
Income Statement Trend
Amwill Health Care Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 30.7M | 32.8M | 68.5M | 24.1M | 488.0K |
Short-term Investments | - | - | 10.1M | - | - |
Accounts Receivable | 167.2M | 129.6M | 12.3M | 8.8M | 44.1M |
Inventory | 5.5M | 4.9M | 31.8M | 20.6M | 25.0M |
Other Current Assets | 4.3M | 3.5M | - | - | - |
Total Current Assets | 220.6M | 174.6M | 113.8M | 56.0M | 72.3M |
Non-Current Assets | |||||
Property, Plant & Equipment | 11.6M | 82.0K | 82.0K | 82.0K | 82.0K |
Goodwill | 2.5M | 2.4M | 309.0K | 563.0K | 802.0K |
Intangible Assets | 2.5M | 2.4M | 309.0K | 563.0K | 802.0K |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 477.9M | - | 2.0K | -2.0K | - |
Total Non-Current Assets | 494.2M | 15.2M | 10.1M | 9.9M | 10.6M |
Total Assets | 714.8M | 189.8M | 123.9M | 65.9M | 82.9M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 11.1M | 2.9M | 51.8M | 24.3M | 50.7M |
Short-term Debt | - | 0 | 350.0K | 1.2M | 1.2M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 7.8M | 30.0K | 27.0K | 333.0K | 6.2M |
Total Current Liabilities | 19.9M | 15.3M | 75.2M | 49.5M | 92.9M |
Non-Current Liabilities | |||||
Long-term Debt | - | - | - | - | - |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | 2.8M | 2.9M | 2.7M | 1.4M | 851.0K |
Total Liabilities | 22.6M | 18.2M | 77.9M | 51.0M | 93.8M |
Equity | |||||
Common Stock | 200.0M | 500.0K | 300.0K | 300.0K | 300.0K |
Retained Earnings | - | 171.1M | 45.7M | 14.6M | -11.2M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 692.2M | 171.6M | 46.0M | 14.9M | -10.9M |
Key Metrics | |||||
Total Debt | 0 | 0 | 350.0K | 1.2M | 1.2M |
Working Capital | 200.8M | 159.3M | 38.6M | 6.4M | -20.6M |
Balance Sheet Composition
Amwill Health Care Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 119.0M | 167.6M | 41.7M | 33.3M | -10.3M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | -53.8M | -109.4M | -13.8M | 28.7M | -37.6M |
Operating Cash Flow | 58.2M | 55.2M | 26.8M | 62.1M | -47.9M |
Investing Activities | |||||
Capital Expenditures | -7.2M | -8.3M | -3.1M | -607.0K | -8.0M |
Acquisitions | - | - | - | - | - |
Investment Purchases | - | - | - | - | - |
Investment Sales | - | - | - | - | - |
Investing Cash Flow | -7.2M | -8.3M | -3.1M | -607.0K | -8.0M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | - | - | - | - | - |
Debt Repayment | 0 | -350.0K | -1.1M | -66.0K | -45.0K |
Financing Cash Flow | 488.8M | -500.0K | -2.0M | -66.0K | 716.0K |
Free Cash Flow | 48.5M | -39.5M | 44.8M | 29.1M | -7.3M |
Net Change in Cash | 539.8M | 46.3M | 21.6M | 61.4M | -55.2M |
Cash Flow Trend
Amwill Health Care Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
8.97
Price to Book
1.72
Price to Sales
2.93
Profitability Ratios
Profit Margin
26.44%
Operating Margin
14.57%
Return on Equity
24.85%
Return on Assets
15.47%
Financial Health
Current Ratio
11.11
Debt to Equity
0.00
Per Share Data
EPS (TTM)
₹6.63
Book Value per Share
₹34.60
Revenue per Share
₹25.08
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
amwill | 1.2B | 8.97 | 1.72 | 24.85% | 26.44% | 0.00 |
Entero Healthcare | 51.9B | 54.82 | 3.01 | 5.36% | 1.90% | 21.76 |
Royal Sense | 1.1B | 17.33 | 3.62 | 27.55% | 10.26% | 11.74 |
NOVELIX | 532.4M | 514.50 | 2.34 | 0.68% | 0.28% | 0.00 |
Trimurthi | 264.8M | 102.35 | 2.40 | 0.00% | 1.85% | - |
Zenlabs Ethica | 214.6M | 78.02 | 1.99 | 2.62% | 0.52% | 121.85 |
Financial data is updated regularly. All figures are in the company's reporting currency.